The
Introduction
Amino acids have proven to play a significant role in the synthesis of novel drug candidates with the use of non-proteinogenic and unnatural amino acids.
One of the most prominent members of coded amino acids is arginine (Arg), which has been intensively studied with the respect to biological properties, and as a building block in peptide chemistry (15) .
Arginine, guanidine-containing amino acid plays an important role in biologically active proteins and peptides, and is involved in many important physiological and pathophysiological processes (1, 2, 8) . The guanidino group of Arg is the important detail of its biological specificity.
L-Canavanine, guanidine-containing nonproteinogenic amino acid is an arginine analogue with the 3-methylene group substituted by an oxygen atom. As an analog and antimetabolite of Larginine, L-canavanine is highly toxic to a wide range of organisms including bacteria, fungi, yeast, algae, plants, insects, and mammals (12) .
L-Canavanine (Cav) has been reported to possess growth retardation activity toward tumor cells in culture and experimental tumors in vivo (6, 16, 17) . Synergic antitumor effects from a combination of L-canavanine with 5-fluorouracil or γ-irradiation have been demonstrated, indicating that L-canavanine may modulate the chemo-or radio-sensitivity of tumors (7, 14) .
In view of this, it was interesting to design and synthesize of unnatural amino acids containing a guanidino functionality (oxy-and sulfoguanidino), as structural analogues of arginine and canavanine (4, 9, 13) . Their effects on the growth of microorganisms, model plant systems, cultured tumor cells and their antitumor activity in vivo have been evaluated (5, 10) . We reported that modification of Cav at the carboxyl group selectively changed toxicity against bacteria, plants and leukemia cells (10) .
In the present study, the cytotoxic activities of sulfo-arginine analogues sArg, NsArg, and their hydrazide derivatives (Fig. 1) 
Materials and Methods
The synthesis of sufoarginines and their hydrazides has been described previously (3, 5) . For the synthesis of the desired compounds, the sequence of reactions shown in synthetic scheme ( Fig. 2) was followed. The synthesis of hydrazides followed the route a, using benzyl ester of the protected sArg or NsArg, respectively. The 3T3 (standard mouse embryonic fibroblast cell line) and HepG2 (human liver hepatocellular carcinoma cell line) cells were cultured in Dulbecco Modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Gibco, Austria), 100 U/ml penicillin and 0.1 mg/ml streptomycin (Lonza, Belgium) under 5% CO 2 atmosphere at 37 o C. Plastic flasks supplied by Greiner, Germany, were used to grow the cells. For experiments the cells in exponential phase of growth after treatment with trypsin-EDTA (FlowLab, Australia) were seeded into 96-well plates (Greiner, Germany) in a concentration 2x10 4 cells/well. 24 hours post seeding, the cultivated cells were treated with amino acid analogues in a wide concentration range (2-0.015 mM). Untreated cells were used as controls.
Cytotoxicity was measured by colorimetric assay based on tetrasolium salt MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (Sigma Chemical Co.). The assay was performed 24 hours after treatment with the amino acid analogues as described elsewhere (11) . ELIZA plate reader (TECAN, Sunrise TM, Grodig/Sazburg, Austria) was used for reading the results. Optical density was determined at a wavelength of 540 nm and a reference wavelength of 620 nm. Cell cytotoxicity determined by MTT assay was expressed as per cent of dead cells. PrizmaPlot.4 (ANOVA-test) was used for statistical analysis.
Results and Discussion
The results of the sArg cytotoxicity on 3T3 and HepG2 cells are shown on Fig. 3A1 and Fig. 3B1 , respectively. As can be seen, only the highest concentration used (2 mM) revealed cell growth inhibitory effect (42% and 17%, respectively). Some lower concentrations of sArg showed cell growth stimulating effects on 3T3 cellsstatistically significant for sArg concentrations 1, 0.5 and 0.125 mM (Fig. 2A1) .
The sArg analogues sArg-CONHNH 2 ( Fig.  3A3 and Fig. 3B3 ) and sArg-CONHNC 6 H 5 ( Fig.  3A4 and Fig. 3B4) The sArg-CONHN(CH 2 CH 2 Cl) 2 ( Fig. 3A5 and  Fig. 3B5 ) showed clear cell growth inhibitory effect on both cell lines, considerably higher with the tumor cells HepG2, where statistically reliable results were achieved for the concentrations: 0.25, 0.5, 1 and 2 mM (Fig. 2B5) . Its IC50 values for 3T3 and HepG2 cells were 1.09 mM and 0.63 mM, respectively.
The cytotoxic activities of NsArg (Fig. 4A1  and Fig. 4B1 ) and its analogues NsArg-CONHNH 2 ( Fig. 4A3 and Fig. 4B3 ), NsArg-CONHNC 6 H 5 ( Fig. 4A4 and Fig. 4B4 ) and NsArg-CONHN(CH 2 CH 2 Cl) 2 (Fig. 4A5 and Fig. 4B5 ) on 3T3 and HepG2 cells were also examined. Their effects on cell growth were lower in comparison with sArg and its analogues, but an increase of the cell growth inhibitory effects was also observed with the modification of the carboxyl group. Highest cell growth inhibitory effect was observed for NsArg-CONHNH 2 ( Fig. 4A3 and Fig. 4B3 ) but only 2 mM concentration revealed such effect.
It may be concluded that the substitution in the carboxylic group of sArg increases the cell growth inhibitory effects of the compounds, especially in the case of the bis-(2-chloroethyl)hydrazide substitute. Similar correlation was observed in the case of NsArg and its analogues, but here the most pronounced effect was observed with the analogue NsArg-CONHNH 2 .
The results confirm our previous findings (16, 17) that the cell growth inhibitory effect of the compounds depends on the modification in the carboxylic group.
